A TRIAL OF INHALED NEBULISED UNFRACTIONATED HEPARIN SODIUM IN PATIENTS WITH STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Trial Profile

A TRIAL OF INHALED NEBULISED UNFRACTIONATED HEPARIN SODIUM IN PATIENTS WITH STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Discontinued
Phase of Trial: Phase II

Latest Information Update: 12 Apr 2016

At a glance

  • Drugs Heparin (Primary)
  • Indications Chronic obstructive pulmonary disease; Embolism and thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Apr 2016 Status changed from recruiting to discontinued, according to European Clinical Trials Database record.
    • 11 Feb 2016 Results (n = 24) were published in an Ockham Biotech media release.
    • 14 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top